Pembrolizumab-induced pneumonitis.

about

Anti PD-1 immunotherapy related interstitial lung disease presenting as respiratory failure - A review with case series

P2860

Q59129657-AB992929-48CA-4E91-A4E6-402FFF4D526A

P2860

Pembrolizumab-induced pneumonitis.

Item

http://www.wikidata.org/entity/Q40222948

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pembrolizumab-induced pneumonitis.

@en

type

Item

label

Pembrolizumab-induced pneumonitis.

@en

prefLabel

Pembrolizumab-induced pneumonitis.

@en

P1476

Pembrolizumab-induced pneumonitis.

@en

P2093

Arnaud Scherpereel

http://www.w3.org/2001/XMLSchema#string

Carole Templier

http://www.w3.org/2001/XMLSchema#string

Clement Fournier

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Faivre

http://www.w3.org/2001/XMLSchema#string

Laurent Mortier

http://www.w3.org/2001/XMLSchema#string

Lidwine Wemeau-Stervinou

http://www.w3.org/2001/XMLSchema#string

Vincent Leroy

http://www.w3.org/2001/XMLSchema#string

P2860

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Nivolumab in previously untreated melanoma without BRAF mutation

Pembrolizumab for the treatment of non-small-cell lung cancer

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

A Case of Organizing Pneumonia (OP) Associated with Pembrolizumab.

P31

scholarly article

P356

10.1183/23120541.00081-2016

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28480216

http://www.w3.org/2001/XMLSchema#string

P932

5413357

http://www.w3.org/2001/XMLSchema#string

Pembrolizumab-induced pneumonitis.

about

P2860

P2860

Pembrolizumab-induced pneumonitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P932